124 related articles for article (PubMed ID: 26405681)
1. Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons.
Shahbazi M; Farnia M; Moradi G; Karamati M; Paknazar F; Mirmohammad Khani M
Int J High Risk Behav Addict; 2015 Jun; 4(2):e23751. PubMed ID: 26405681
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study.
Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E
J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625
[TBL] [Abstract][Full Text] [Related]
3. Tattooing among Iranian prisoners: results of the two national biobehavioral surveillance surveys in 2015-2016.
Jafari S; Moradi G; Zareie B; Gouya MM; Zavareh FA; Ghaderi E
An Bras Dermatol; 2020; 95(3):289-297. PubMed ID: 32276795
[TBL] [Abstract][Full Text] [Related]
4. Injecting drug use in prison: prevalence and implications for needle exchange policy.
Wright NM; Tompkins CN; Farragher TM
Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
[TBL] [Abstract][Full Text] [Related]
5. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
Chakrapani V; Kamei R; Kipgen H; Kh JK
Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
[TBL] [Abstract][Full Text] [Related]
6. A Senior Management Perspective on the Policy Debate of Needle and Syringe Exchange Program Provision in Irish Prisons.
Rosalim JP
J Correct Health Care; 2020 Jan; 26(1):27-35. PubMed ID: 31983260
[TBL] [Abstract][Full Text] [Related]
7. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
8. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
9. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
[TBL] [Abstract][Full Text] [Related]
10. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
Tompkins CN
Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
[TBL] [Abstract][Full Text] [Related]
11. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
[TBL] [Abstract][Full Text] [Related]
12. The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?
Treloar C; McCredie L; Lloyd AR
PLoS One; 2016; 11(9):e0162399. PubMed ID: 27611849
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
15. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
17. Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners.
Moller LF; van den Bergh BJ; Karymbaeva S; Esenamanova A; Muratalieva R
Int J Prison Health; 2008; 4(3):124-33. PubMed ID: 18698527
[TBL] [Abstract][Full Text] [Related]
18. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment.
Stark K; Müller R; Wirth D; Bienzle U; Pauli G; Guggenmoos-Holzmann I
Addiction; 1995 Oct; 90(10):1367-75. PubMed ID: 8616465
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis.
Behzadifar M; Gorji HA; Rezapour A; Bragazzi NL
Harm Reduct J; 2018 May; 15(1):24. PubMed ID: 29739400
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
